Volume 11, Issue 1 (Int J Mol Cell Med 2022)                   Int J Mol Cell Med 2022, 11(1): 64-77 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saber Amoli S, Hasanzadeh A, Sadeghi F, Chehrazi M, Seyedmajidi M, Zebardast A et al . Prevalence of Co-infection by Human Papillomavirus, Epstein-Barr Virus and Merkel Cell Polyomavirus in Iranian Oral Cavity Cancer and Pre-malignant Lesions. Int J Mol Cell Med 2022; 11 (1) :64-77
URL: http://ijmcmed.org/article-1-1873-en.html
Prevalence of Co-infection by Human Papillomavirus, Epstein-Barr Virus and Merkel Cell Polyomavirus in Iranian Oral Cavity Cancer and Pre-malignant Lesions
Sagahr Saber Amoli1 , Ali Hasanzadeh2 , Farzin Sadeghi3 , Mohammad Chehrazi4 , Maryam Seyedmajidi5 , Arghavan Zebardast6 , Yousef Yahyapour7
1- Department of Medical Microbiology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
2- Department of Medical Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
3- Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
4- Department of Biostatistics and Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol, Iran.
5- Dental Materials Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
6- Department Medical Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
7- Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. , uyahyapoor@yahoo.com
Abstract:   (3350 Views)
Human papillomavirus (HPV) is recognized as a most important risk factor in oral cavity cancer and pre-malignant lesions; however, etiological association of concomitant infection with other oncogenic viruses as a co-factor has not been definitively proven. The present study aimed to determine the prevalence of co-infection with HPV, Epstein–Barr virus (EBV) and Merkel Cell PolyomaVirus (MCPyV) in oral cavity lesions in Iranian patients. One hundred and fourteen oral cavity samples, including 33 oral squamous cell carcinoma, 28 oral lichen planus, 16 oral epithelial dysplasia and 37 oral irritation fibromas were analyzed for the HPV, EBV and MCPyV infection by quantitative real-time PCR. According to histological features 32.5% and 28.9% of cases were oral irritation fibroma and oral squamous cell carcinoma, respectively. Infection with at least two viruses was detected in 21.1% of patients. In this group, co-infection with HPV/EBV was identified in 37.5% of cases, HPV/MCPyV in 29.2%, EBV/MCPyV in 12.5%, and HPV/EBV/MCPyV in 20.8%. There was no statistically significant difference between multiple infections and anatomical locations of cancer. The prevalence of triple viral infection (HPV/EBV/MCPyV) in well differentiated tumors was higher than EBV or MCPyV single infection. This study revealed that co-infection of HPV, EBV and MCPyV can be detected in both malignant and non-malignant oral cavity tissues, and co-infection with all three viruses in well differentiated tumors can be shown as a synergistic hypothesis of the pathogenic role of these viruses in oral malignant transformation.
 
Keywords: Co-infection, human papillomavirus (HPV), Merkel cell polyomavirus (MCPyV), Epstein–Barr virus (EBV), oral lesions
Full-Text [PDF 441 kb]   (1372 Downloads)    
Type of Study: Original Article | Subject: Infectious disease (Molecular and Cellular aspects)
Received: 2022/02/20 | Accepted: 2022/06/11 | Published: 2022/06/20
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | International Journal of Molecular and Cellular Medicine IJMCM

Designed & Developed by : Yektaweb